SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Brand Engagement Network, Inc. engages in the provision of conversational artificial intelligence assistants with the purpose of transforming engagement and analytics for businesses through security-focused, multimodal communication and human-like artificial intelligence assistants. The firm is also involved in delivering highly personalized, multi-modal artificial intelligence engagement with a focus on industries where there is a massive workforce gap and an opportunity to transform how consumers engage with networks, providers, and brands. The company is founded on March 14, 2024 and is headquartered in Jackson, WY.

Brand Engagement Network Inc

Brand Engagement Network Inc (BNAI) is surging, fueled by its low float and high short interest, igniting intense community discussion around a monumental short squeeze. Traders are celebrating exponential gains and drawing comparisons to past historic runners, while also noting a recent $2 million deal and broader AI sector enthusiasm as potential catalysts. Despite widespread excitement, some caution about the extreme valuation and potential volatility.

Q/C Technologies, Inc. operates as a clinical-stage pharmaceutical company, which engages in the development of drug products to extend healthy lifespan. It focuses on developing two novel therapeutic platforms, MyMD-1 and SUPERA-CBD, which aim to treat the causes of disease rather than just addressing the symptoms. MyMD-1 is a clinical-stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and other pro-inflammatory cytokines. SUPERA-CBD is a synthetic derivative of cannabidiol being developed to treat conditions such as epilepsy, chronic pain, depression, as well as neuroinflammatory and neurodegenerative diseases. The company was founded in 1989 and is headquartered in New York, NY.

Q/C Technologies Inc.

Q/C Technologies Inc. is generating significant buzz due to the recent appointment of OpenAI's Chelsea Voss to its board and the strategic involvement of Martin Shkreli. The community is actively discussing the company's potential as a quantum computing play, with many anticipating substantial price appreciation and a possible short squeeze given its low float. Investors are comparing its current setup to previous high-growth opportunities, fueling excitement for its future trajectory.

Cadrenal Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapy. It develops tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was founded by Quang X. Pham and Matthew K. Szot on January 25, 2022 and is headquartered in Ponte Vedra, FL.

Cadrenal Therapeutics Inc

Cadrenal Therapeutics, Inc.

Cadrenal Therapeutics is trending due to advancements in its anticoagulation pipeline, including the Phase 3-ready tecarfarin with FDA Fast Track status and the recent acquisition of VLX-1005 for heparin-induced thrombocytopenia. Community sentiment is sharply divided, with supporters emphasizing the large market opportunity and collaborations like that with Abbott, while detractors express concerns over frequent offerings, cash burn, and perceived promotional activity.

SSgA Active Trust - State Street Utilities Select Sector SPDR ETF

Utilities Select Sector SPDR Fund

The Utilities Select Sector SPDR Fund ($XLU) is trending due to the increasing power demands from the AI boom, which is transforming the sector from a traditional defensive play into a growth opportunity. Community discussions highlight its dual appeal as a safe haven amidst broader market uncertainties and a beneficiary of a structural shift in electricity consumption. Many investors are actively monitoring its strong price action, considering it a crucial 'AI power play' within their portfolios.

Eos Energy Enterprises, Inc. designs, manufactures, and deploys battery storage solutions for the electricity industry. It offers the Eos Znyth DC battery system product which designs to meet the requirements of the grid-scale energy storage market. The company was founded in 2008 and is headquartered in Edison, NJ.

Eos Energy Enterprises Inc - Ordinary Shares - Class A

Eos Energy is generating significant buzz following the launch of its InDensity battery storage platform, touted for its high density and safety features critical for grid-scale and AI data center power demands. The community is keenly anticipating further updates and potential large-scale partnerships, alongside high short interest, as discussions around U.S. domestic battery solutions intensify.

BitGo Holdings, Inc. provides cryptocurrency custody solutions. It offers self-custody wallet, qualified custody, liquidity and prime, and infrastructure-as-a-service. The company was founded by Michael Belshe in 2013 and is headquartered in Palo Alto, CA.

BitGo Holdings Inc. - Ordinary Shares - Class A

BTGO is a focal point of market discussion after its recent public debut saw shares quickly trade significantly below their initial offering price, sparking intense debate among investors. The community is split, with many decrying it as a "busted IPO" while others see a compelling "value buy," emphasizing its profitable institutional crypto infrastructure and high short interest as potential catalysts for a rebound. This sharp divergence underscores the high stakes for a company positioned as a key player with a regulatory moat in the evolving digital asset landscape.

TMC the metals co., Inc. is a deep-sea minerals exploration company focused on the collection and processing of polymetallic nodules found on the seafloor in international waters of the Clarion Clipperton Zone in the Pacific Ocean (CCZ). These nodules contain high grades of four metals (nickel, copper, cobalt, manganese) which can be used as (i) feedstock for battery cathode precursors (nickel, cobalt and manganese sulfates, or intermediate nickel-copper-cobalt matte) for electric vehicles (EV) and renewable energy storage markets, (ii) copper cathode for EV wiring, energy transmission and other applications and (iii) manganese silicate for manganese alloy production required for steel production. The company was founded in 2021 and is headquartered in Vancouver, Canada.

TMC the metals company Inc

TMC is actively discussed after recent regulatory updates by NOAA facilitated its consolidated permit application for deep-sea mineral exploration and recovery, significantly expanding its potential operational scope. The community is highly bullish, citing strong government backing for critical mineral independence and national security, with many anticipating substantial upside and a potential short squeeze, even as some express caution about production timelines and environmental considerations.

Occidental Petroleum Corp. engages in the exploration and production of oil and natural gas. It operates through the following segments: Oil and Gas, Chemical, and Midstream and Marketing. The Oil and Gas segment explores for, develops and produces oil and condensate, natural gas liquids, and natural gas. The Chemical segment manufactures and markets basic chemicals and vinyls. The Midstream and Marketing segment purchases, markets, gathers, processes, transports and stores oil, condensate, natural gas liquids, natural gas, carbon dioxide, and power. The company was founded in 1920 and is headquartered in Houston, TX.

Occidental Petroleum Corp.

Occidental Petroleum is actively trending following its $9.7 billion cash sale of OxyChem to Berkshire Hathaway, a strategic move aimed at accelerating debt reduction and strengthening its balance sheet. Community discussions are focused on the company's leaner, oil-and-gas-centric future, with many anticipating potential dividend increases and a broader energy sector rebound amidst global uncertainties.

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

Ocular Therapeutix Inc

Ocular Therapeutix is a major talking point amid swirling rumors of an improved takeover bid from Sanofi, following reports an earlier $16 per share offer was rejected. This, combined with the company's strategic acceleration of its AXPAXLI FDA submission pathway and a high-profile commercial officer hire, has the community actively debating the potential for strong clinical data or an imminent acquisition at a significant premium.

Volatility Shares Trust - 2x Long VIX Futures ETF

Volatility Shares 2x Long VIX Futures ETF

UVIX is highly active as geopolitical tensions, particularly surrounding Iran and the Greenland acquisition discussions, heighten market uncertainty and inflation concerns. The community is sharply divided, with some actively trading this leveraged volatility product for potential spikes while others warn against its inherent decay and suitability only for extremely short-term plays.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Massachusetts Financial Services Co. MA Acquires 577,899 Shares of Schrodinger, Inc. $SDGR

Massachusetts Financial Services Co. MA grew its holdings in Schrodinger, Inc. (NASDAQ:SDGR - Free Report) by 38.7% during the third quarter, according to its most recent disclosure with the...

86,319 Shares in Schrodinger, Inc. $SDGR Acquired by Campbell & CO Investment Adviser LLC

Campbell & CO Investment Adviser LLC acquired a new stake in shares of Schrodinger, Inc. (NASDAQ:SDGR - Free Report) in the 3rd quarter, according to its most recent 13F filing with the SEC. The fund...

Stephens Investment Management Group LLC Trims Stock Holdings in Schrodinger, Inc. $SDGR

Stephens Investment Management Group LLC decreased its position in Schrodinger, Inc. (NASDAQ:SDGR - Free Report) by 3.0% in the third quarter, according to the company in its most recent disclosure...

Schrodinger (NASDAQ:SDGR) Shares Down 5.2% - Time to Sell?

Schrodinger (NASDAQ:SDGR) Shares Down 5.2% - Here's Why...

Schrdinger Provides Update on Progress Across the Business and Outlines 2026 Strategic Priorities

Schrdinger, Inc. (Nasdaq: SDGR) provided an update on its progress across the business in 2025 and announced its strategic priorities for 2026. The company is continuing to focus on advancing its...

Schrodinger (NASDAQ:SDGR) Price Target Lowered to $24.00 at TD Cowen

TD Cowen reduced their price target on Schrodinger from $33.00 to $24.00 and set a "buy" rating on the stock in a research report on Thursday...

KeyCorp Issues Pessimistic Forecast for Schrodinger (NASDAQ:SDGR) Stock Price

KeyCorp dropped their price objective on shares of Schrodinger from $28.00 to $25.00 and set an "overweight" rating for the company in a report on Thursday...

BFLY to Extend 3D Imaging Capabilities to Butterfly Garden Developers

Butterfly Network targets a 2026 Beam Steering API, opening core imaging to developers and enabling AI tools in Butterfly Garden.

CapsoVision Submits FDA 510(k) for AI-Assisted Module in CapsoCam Plus

CV seeks FDA clearance to add AI-based reading to CapsoCam Plus to boost diagnostic accuracy and streamline reviews.

KRMD Submits 510(k) to Use FreedomEDGE System With Oncology Biologic

KORU Medical filed a 510(k) to use FreedomEDGE for subcutaneous PHESGO delivery, expanding into oncology and simplifying breast cancer care.

Schrödinger, Inc. engages in the provision of chemical simulation software solutions to pharmaceutical industry. It operates through the Software and Drug Discovery business segments. The Software segment sells software to transform drug discovery across the life sciences industry and to customers in materials science industries. The Drug Discovery segment offers diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have advanced to various stages of discovery and development. The company was founded by Richard A. Friesner, William A. Goddard, III and Murco Ringnalda in 1990 and is headquartered in New York, NY.

Schrodinger Inc

$MSFT

$AAPL

$TSLA

$META

Earnings season is heating up, and several major companies report next week, including Microsoft, Apple, Tesla, and Meta. Which are you most excited for?

Which earnings report are you most excited for next week? 
 
Drop a comment for others.

SDGR
Schrodinger Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest SDGR News

SDGRSchrodinger Inc